Clinical trial
Efficacy and Safety of Alprostadil Liposomes for Injection in the Treatment of Atherosclerotic Occlusive Disease of the Lower Extremities-A Phase II Multi-center Randomised Controlled Trial
NCT02877173 is registered in ClinicalTrials.gov with Guangzhou Yipinhong Pharmaceutical CO.,LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Alprostadil Liposomes for Injection in the Treatment of Atherosclerotic Occlusive Disease of the Lower Extremities-A Phase II Multi-center Randomised Controlled Trial
- Lead sponsor
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2016
- Completion date
- December 31, 2017
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.